- Letter
- Open Access
- Published:
Extracorporeal myoglobin removal in severe rhabdomyolysis with high cut-off membranes—intermittent dialysis achieves much greater clearances than continuous methods
Critical Care volume 25, Article number: 97 (2021)
Weidhase et al. recently published a randomized controlled trial comparing two renal replacement modalities regarding myoglobin clearance [1]. The authors found superior myoglobin clearance with a high cut-off (HCO) dialyzer running in continuous veno-venous hemodialysis (CVVHD) mode compared to a standard, high-flux dialyzer running in continuous veno-venous hemodiafiltration (CVVHDF) mode [1], which is not surprising, given the properties of HCO membranes. HCO dialyzers were first used in intermittent hemodialysis with the aim of free light chains [2] and myoglobin removal [3], but have later also been used with continuous dialysis techniques, mainly with the aim of improving clearance of inflammatory cytokines.
The authors concluded that CVVHD using HCO dialyzers could be beneficial in patients with acute kidney injury and high myoglobin levels [1]. We would like to emphasize that intermittent hemodialysis would be more suitable than continuous methods for the treatment of severe rhabdomyolysis-associated acute kidney injury (AKI). While myoglobin clearance was indeed higher in the HCO-CVVHD group, the absolute values were expectedly low, about 8–10 ml/min [1], because continuous methods have low clearances by design and cannot fully take advantage of the HCO membranes. On the other hand, using HCO dialyzers with intermittent dialysis a much greater median myoglobin clearance of 77 ml/min in hemodialysis [4] and 93 ml/min in hemodiafiltration mode [3] was reported. Although continuous methods compensate for low clearance by prolonged dialysis time, removal of clinically significant amounts of myoglobin is difficult to achieve. There is only one case report describing significant removal with high-dose continuous veno-venous hemofiltration (at 4 l/h of infusate) in a patient with very severe but transient rhabdomyolysis due to serotonin syndrome [5]. Such high-intensity continuous dialysis is quite cumbersome to perform and also costly, while intermittent dialysis can easily achieve effective myoglobin removal in 6–8-h sessions [3, 4], which can be extended to 12 h in extreme cases. The new medium cut-off membranes may prove to be an even more effective method for extracorporeal myoglobin removal because they cause less albumin loss.
In conclusion, while the role of extracorporeal myoglobin removal in severe rhabdomyolysis-associated acute kidney injury is not yet established, we suggest using HCO dialyzers with intermittent or extended dialysis techniques to achieve optimal myoglobin clearance in a cost-effective and time-efficient way.
Availability of data and materials
Not applicable.
References
Weidhase L, de Fallois J, Haußig E, Kaiser T, Mende M, Petros S. Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial. Crit Care. 2020;24(1):644.
Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol. 2009;4(4):745–54.
Premru V, Kovac J, Buturovic-Ponikvar J, Ponikvar R. Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure. Ther Apher Dial. 2013;17(4):396–401.
Heyne N, Guthoff M, Krieger J, Haap M, Häring HU. High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series. Nephron Clin Pract. 2012;121(3–4):c159–64.
Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R. Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care. 2005;9(2):R90–5.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
JG conceived the letter, and VPe, AJ and VPr revised it. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
JG reports receiving reimbursements and speaking honoraria from Baxter. Other authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Gubensek, J., Persic, V., Jerman, A. et al. Extracorporeal myoglobin removal in severe rhabdomyolysis with high cut-off membranes—intermittent dialysis achieves much greater clearances than continuous methods. Crit Care 25, 97 (2021). https://doi.org/10.1186/s13054-021-03531-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13054-021-03531-7